Calcium channel blockers for tardive dyskinesia in geriatric psychiatric patients

1 September 1989

journal article
research article
Published by American Psychiatric Association Publishing in American Journal of Psychiatry

Vol. 146 (9) , 1218-1219
https://doi.org/10.1176/ajp.146.9.1218

Abstract

Nifedipine treatment resulted in variable improvement in tardive dyskinesia in eight geriatric psychiatric patients. Patients with affective disorders and hypertension demonstrated improvement in other areas as well.

This publication has 9 references indexed in Scilit:

DILTIAZEM FOR TARDIVE DYSKINESIA AND TARDIVE DYSTONIA
The Lancet, 1988
Pimozide in the Management of Psychotically Agitated Demented Patients
Journal of the American Geriatrics Society, 1987
Clinical and Biochemical Effects of Verapamil Administration to Schizophrenic Patients
Archives of General Psychiatry, 1987
DILTIAZEM FOR TARDIVE DYSKINESIA
The Lancet, 1987
An anti-tardive-dyskinesia effect of verapamil
American Journal of Psychiatry, 1986
Use of calcium antagonists in mania
Psychoneuroendocrinology, 1986
Antischizophrenic drugs of the diphenylbutylpiperidine type act as calcium channel antagonists.
Proceedings of the National Academy of Sciences, 1983
Epidemiology of Tardive Dyskinesia
Clinical Neuropharmacology, 1983
Research Diagnoses for Tardive Dyskinesia
Archives of General Psychiatry, 1982